Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $86.25 USD
Change Today -0.13 / -0.15%
Volume 262.7K
HTWR On Other Exchanges
Symbol
Exchange
NASDAQ GS
OTC US
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

heartware international inc (HTWR) Snapshot

Open
$85.82
Previous Close
$86.38
Day High
$87.09
Day Low
$83.64
52 Week High
04/13/15 - $95.59
52 Week Low
12/11/14 - $69.05
Market Cap
1.5B
Average Volume 10 Days
267.2K
EPS TTM
$-2.44
Shares Outstanding
17.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HEARTWARE INTERNATIONAL INC (HTWR)

heartware international inc (HTWR) Related Bloomberg News

View More Bloomberg News

heartware international inc (HTWR) Related Businessweek News

No Related Businessweek News Found

heartware international inc (HTWR) Details

HeartWare International, Inc., a medical device company, designs, develops, manufactures, and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure in the United States, Germany, and internationally. It offers HeartWare Ventricular Assist System, which comprises a VAD or blood pump, patient accessories, and surgical tools designed to provide circulatory support for patients in the advanced stage of heart failure. The company is also developing the MVAD, a miniaturized blood pump intended for chronic heart failure patients; and SYNERGY Circulatory Support System, a partial support system designed to treat less sick, ambulatory, chronic heart failure patients who are not yet inotrope-dependent. The company markets its products directly to clinicians and medical facilities, as well as through medical device distributors. HeartWare International, Inc. is headquartered in Framingham, Massachusetts.

585 Employees
Last Reported Date: 03/2/15

heartware international inc (HTWR) Top Compensated Officers

Chief Executive Officer, President, Managing ...
Total Annual Compensation: $558.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $334.6K
Chief Scientific Officer and Executive Vice P...
Total Annual Compensation: $331.6K
Senior Vice President, General Counsel and Se...
Total Annual Compensation: $329.2K
Senior Vice President of Research & Developme...
Total Annual Compensation: $276.4K
Compensation as of Fiscal Year 2014.

heartware international inc (HTWR) Key Developments

Heartware International Inc. Completes Enrollment in ENDURANCE2 Supplemental Destination Therapy Trial

HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical trial has been completed. ENDURANCE2 is the large destination therapy clinical trial of a ventricular assist device conducted to date and is designed to evaluate patients implanted with the HeartWare® Ventricular Assist System for long-term use as destination therapy in the United States. Data from the ENDURANCE program are expected to form the basis for a Pre-Market Approval (PMA) Application seeking approval of the HeartWare System for destination therapy.

Heartware International Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

Heartware International Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. The company announced total revenue of $73.6 million for the quarter ended June 30, 2015 compared to $70.1 million for the quarter ended June 30, 2014. Currency fluctuations impacted revenue growth by approximately $6.0 million, or nine percentage points, during the three months ended June 30, 2015, as compared to the same period in 2014. Total revenues increased 13% on a constant-currency basis compared to the same period in 2014. Net loss for the second quarter of 2015 was $27.4 million, or a loss of $1.59 per basic and diluted share, compared to net income of $8.4 million, or $0.49 per basic and $0.48 per diluted share, for the second quarter of 2014. Non-GAAP net loss for the second quarter of 2015 was $8.1 million, or a loss of $0.47 per basic and diluted share, compared to a non-GAAP net loss of $4.9 million, or a loss of $0.29 per basic and diluted share, for the second quarter of 2014. Loss from operations was $7.848 million against income from operations of $13.015 million a year ago. Loss before taxes was $27.087 million against income before taxes of $8.717 million a year ago. For the six months ended June 30, 2015, total revenue increased approximately 5% to $143.6 million, compared to $136.6 million for the same period in 2014. Total revenue increased 13% on a constant-currency basis compared to the first six months of 2014. For the six months ended June 30, 2015, the company recorded a net loss of $41.9 million, or a loss of $2.43 per basic and diluted share, compared to a net loss of $11.1 million, or a loss of $0.65 per basic and diluted share, for the six months ended June 30, 2014. Non-GAAP net loss for the six months ended June 30, 2015 was $17.5 million, or a loss of $1.02 per basic and diluted share, compared to a non-GAAP net loss of $16.8 million, or a loss of $0.99 per basic and diluted share, for the six months ended June 30, 2014. Loss from operations was $15.163 million against $3.391 million a year ago. Loss before taxes was $41.391 million against $10.505 million a year ago.

Heartware International Inc. to Report Q2, 2015 Results on Jul 30, 2015

Heartware International Inc. announced that they will report Q2, 2015 results at 8:00 AM, US Eastern Standard Time on Jul 30, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTWR:US $86.25 USD -0.13

HTWR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
ABIOMED Inc $98.23 USD +0.03
Getinge AB kr192.40 SEK -0.20
Sunshine Heart Inc $2.86 USD +0.20
Teleflex Inc $132.49 USD -0.61
Thoratec Corp $62.59 USD +0.20
View Industry Companies
 

Industry Analysis

HTWR

Industry Average

Valuation HTWR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEARTWARE INTERNATIONAL INC, please visit www.heartware.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.